Do Statins Increase or Decrease the Risk of Depression?

Plenty of people starting a statin worry it might dampen their mood. For most users, the evidence points the other way, or to no effect at all. Large studies of whole populations find that statin users are, if anything, slightly less likely to become depressed. The picture does depend partly on which statin and how much of it, so a single blanket answer doesn’t fit everyone. Researchers are even testing statins as an add-on treatment for depression, an unexpected turn for a cholesterol drug.

What Large Studies Show About Statins and Mood

The biggest studies lean toward a small protective link. Across Sweden’s whole population, people had about 9% lower rates of depression during the periods they were taking a statin.¹ One pooled review of many studies found statin users about 16% less likely to develop depression than non-users.² Another pooled review³, after correcting for studies that may have gone unpublished, found no clear link either way.⁴

The reviews differ because the studies behind them came from different countries, age groups and health conditions, and defined depression in different ways. Some counted diagnoses in medical records, while others used symptom questionnaires.

A 9% or 16% lower risk is a relative change, so if few people were going to become depressed anyway, the number actually spared is small. A statin is prescribed to protect your heart, not to treat mood, so the sensible takeaway is reassurance rather than a reason to start one for your spirits.

These studies also observe people rather than randomly assign pills, so they can’t settle cause and effect. The people who end up on statins are those whose doctors checked their cholesterol and prescribed one, which already sets them apart from people who never get checked. Healthier or more active people may be more likely to take statins. People who see doctors regularly and fill prescriptions may also be more likely to have depression noticed and treated, which changes how often it appears in records. A small apparent benefit could therefore partly reflect who takes statins, not the drug itself. A randomized trial, where chance decides who gets the statin, is the cleaner test, but trials built mainly for heart outcomes rarely track mood carefully. These studies describe averages across many people, so they can’t rule out an individual reaction, which is covered below.

How Statin Type and Dose Change the Picture

Statins differ in how easily they reach the brain. Some, such as simvastatin, lovastatin and atorvastatin, are fat-soluble, which likely lets them cross into the brain more easily. Others, such as rosuvastatin and pravastatin, are water-soluble.⁵ In a matched group of almost 300,000 new statin users, fat-soluble statins overall did not clearly raise depression risk compared with water-soluble ones.⁶ Simvastatin alone was tied to about 9% higher risk than water-soluble statins.⁷ Fat-soluble doesn’t mean harmful: the same statins that showed small risk signals also helped mood in some treatment trials, so solubility alone doesn’t predict your outcome.

Dose may matter more than type. In one large analysis, people on low doses (up to 20 mg of simvastatin, pravastatin or lovastatin, or up to 10 mg of atorvastatin or rosuvastatin) had less diagnosed depression than people not on statins.⁸ Above those doses the pattern reversed, with simvastatin 40–60 mg linked to over twice the rate and 60–80 mg to about five times.⁹ Atorvastatin above 10 mg and rosuvastatin 20–40 mg showed the same rising trend.¹⁰

That was a snapshot, and people on high doses often have more serious heart disease, which itself raises depression risk. Doctors choose higher doses or stronger statins when heart risk is high, for example after a heart attack or with very high LDL cholesterol. So the high-dose link is a signal worth knowing, not proof the dose causes depression.

The dose cutoffs only make sense for the specific drug, because 20 mg of one statin is not equal in strength to 20 mg of another. Rosuvastatin and atorvastatin are stronger per milligram than simvastatin or pravastatin, which is why their cutoffs are lower or different. Your pharmacist can tell you where your dose sits for your particular drug.

Your pill bottle or pharmacy label lists the drug name and the milligrams per tablet. Brand names map to generics: Zocor is simvastatin, Lipitor is atorvastatin, Crestor is rosuvastatin and Pravachol is pravastatin. Many people with past heart attacks are deliberately on high doses because they cut heart risk the most. If you’re on a high dose and feel low, the question for your doctor is whether you need that intensity, not whether to stop. Never lower a dose yourself; ask whether a different statin or dose fits your heart risk.

Why a Cholesterol Drug Might Affect Mood

People with depression tend to have higher levels of inflammation in the blood, and statins lower inflammation.¹¹ They also reduce C-reactive protein, a blood marker of inflammation your doctor may test.¹² Inflammation is the body’s defense response, and when it stays switched on at a low level it is linked to both clogged arteries and low mood. That gives a plausible reason one drug could touch both problems, even though it was designed only to lower cholesterol.

In one small trial of depressed patients, low-dose statins changed blood flow in brain areas that control mood and improved symptoms.¹³ The mood benefit in trials did not track how much cholesterol fell, which suggests it works through other routes.¹⁴ Still, this is a theory supported by trial hints. It explains why a benefit is possible, not that statins treat depression.

A route for harm has also been proposed. Brain cells need cholesterol, and in lab-grown cells, removing it with a statin weakened receptors for serotonin, a mood chemical.¹⁵ That was seen in cells, not people. Doses cells see in a dish may be far from what brain tissue sees after a pill passes through the gut, blood and liver and the barrier that shields the brain.

You may also have read that low cholesterol causes depression or suicide. Brain cholesterol is mostly made inside the brain, separate from blood cholesterol, so a statin lowering your blood numbers doesn’t mean your brain runs short.

If Your Mood Changes After Starting a Statin

Real reactions are rare but documented. In a series of 12 people, mood problems such as irritability, depression and violent thoughts began after starting a statin. Their symptoms went away when the statin stopped and returned when it was restarted.¹⁶ For a small number of people, then, a statin may genuinely affect mood.

A group of 12 shows a reaction can happen, but not how often. The stop-and-restart pattern makes these cases persuasive, since a coincidence would be less likely to repeat on cue, though expectation can still play a part.

Expectation and other causes explain many side effects. Expecting harm from a medicine can make you feel side effects you otherwise wouldn’t, known as the nocebo effect.¹⁷ In a trial where people rotated between statin and dummy pills, 90% of the symptoms they recorded on statins also appeared on the dummy pills.¹⁸ People with statin-linked muscle pain also scored higher for anxiety and depression, though most were in the normal range.¹⁹ Pain or worry can feed low mood without the drug acting on the brain.

A nocebo effect doesn’t mean symptoms are imaginary; they come from expectation, not the drug’s chemistry. A real drug reaction tends to follow the medicine, appearing after starting or raising a dose and easing when it’s stopped under a doctor’s guidance.

Start by noting when the mood change began and whether it followed a new statin or a dose increase. A simple record helps: rate your mood from 1 to 10 each day for two to four weeks, mark any dose changes or missed pills, and bring the record along so the pattern, not memory, guides the decision.

Then tell your doctor rather than stopping, since stopping raises heart attack and stroke risk. Expect questions about timing, sleep, stress, other new medicines and life changes. Your doctor may suggest a brief pause, a lower dose or a switch to see if mood lifts, and low mood that returns when the statin restarts is one of the strongest signs it’s the drug. Thyroid problems and vitamin deficiencies can also cause low mood and may be checked. If you have thoughts of harming yourself, seek urgent help right away.

Statins Alongside Antidepressants

SSRIs are the most common antidepressants, and include citalopram, fluoxetine and sertraline. In three small trials with 172 people, adding a statin to an SSRI improved depression more than the SSRI alone.²⁰ Atorvastatin, lovastatin and simvastatin all helped when added to citalopram or fluoxetine.²¹ Larger trials are still needed before this becomes standard treatment.²² Small trials can overstate effects, and these were short, so they can’t show whether the benefit lasts.

The idea behind it is that many people with depression have raised inflammation, and calming it may help an antidepressant work better in those people. That is a hypothesis, and the trials weren’t designed to show which patients benefit or why. Not everyone with depression has high inflammation, so any benefit may not apply to everyone.

Real-world users did better too. Across Denmark, people taking an SSRI plus a statin had about 36% fewer hospital visits for depression than those on an SSRI alone.²³ Because this came from national records and not a trial, people who got both drugs may differ from those on an SSRI alone in health or in how closely they were monitored.

If you take both, there’s no evidence the pairing worsens depression. Tell both prescribers every medicine you take so they can check doses and interactions. And don’t start a statin for mood; this is research, not a reason to prescribe.

Older Adults and Heart or Stroke Patients

After a heart attack, statin users had a much lower risk of depression, by up to 80% in some studies.²⁴ After a stroke, statin users had lower depression risk and better mood scores over the following year.²⁵ Pooled stroke studies disagreed, however, with European studies showing less depression and some Asian studies more.²⁶ The dependable message is that no clear harm shows up after stroke, and some studies hint at protection.

Depression is common after a heart attack or stroke because of the shock, the physical limits and the fear of it happening again. Statins are usually prescribed to these patients for the heart or brain benefit, so any mood benefit is a possible bonus, not the reason for treatment. Because everyone studied was seriously ill, the results can’t be applied to someone taking a statin for cholesterol with no heart event.

In the oldest users the signal flips. Among community-living people aged 75 to 84, statin users had about 21% more depressive symptoms.²⁷ In a study of older people living at home, statin users more often had memory problems and depression.²⁸ These were snapshots, and sicker older people may simply be more likely to take statins. A difference seen at one point in time can’t show whether the statins or the symptoms came first, and older statin users are more likely to have several illnesses, take many medicines and have less mobility.

For an older person or a carer, low mood can look like fatigue, withdrawal or memory slips. Report these changes rather than assuming they’re just ageing. Ask the doctor whether the dose still matches current heart risk, and weigh any mood concern against the statin’s protection from stroke and heart attack.

Other Cholesterol Options If Mood Is a Concern

People on PCSK9 inhibitor injections developed depression less often than people on statins, 3.1% versus 5.5%.²⁹ Genetic studies found no mood side effects from the way ezetimibe lowers cholesterol.³⁰ The PCSK9 finding comes from an early unreviewed report, and these drugs cost more.³¹

The people receiving injections may also differ from the statin group, for example in income, access to care or earlier statin experience. The result is a hint that these drugs are not worse for mood, not proof that they are better.

Ezetimibe works in the gut, reducing how much cholesterol from food and bile is absorbed, rather than slowing the liver’s production the way a statin does. That makes it a different kind of drug for people who can’t tolerate statins. The genetic evidence is indirect, since it looks at gene variants that mimic the drug’s effect and not at people actually taking it.

A switch conversation usually starts with another statin or a lower dose. Ezetimibe is a daily pill, often added to a statin or used instead of one. PCSK9 inhibitors are injections every two to four weeks and often need insurance approval. Any switch should keep your cholesterol target in view.